Answers are grounded in this paper and cite their sources.
QbD approach improves validation and estimation of sulbactam and durlobactam in pharmaceutical dosage forms.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kancharana et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: